Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Samsca in Cirrhotic Patients with Ascites and Hyponatremia
NCT01552590Phase 4Terminated
- Sponsor
- Otsuka Holdings
- Start
- Apr 2012
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tolvaptan in hyponatremia, ascites, sponsored by Otsuka Holdings. Started Apr 2012; status: terminated.
02
Drugs
tolvaptan
03
Conditions
hyponatremiaascites
Beyond the preview
Go deeper on NCT01552590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01552590.